Indaptus Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $16,378,474.
Profit Margin
| 2014 | 0 | -5.69M | |
|---|---|---|---|
| 2015 | 0 | -7.17M | |
| 2017 | 0 | -28.90M | |
| 2019 | 0 | -47.59M | |
| 2020 | 0 | -3.56M | |
| 2021 | 0 | -7.69M | |
| 2022 | 0 | -13.73M | |
| 2023 | 0 | -15.42M |
INDP Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.28K | 1.78K | 1.40K | 852 | 854K | 829K | 745.90K | 584.81K |
Gross profit | -1.28K | -1.78K | -1.40K | -852 | -854K | -829K | -745.90K | -584.81K |
Operating exp. | ||||||||
Research and development | 7.62M | 6.32M | 2.52M | 2.65M | 26.65M | 24.29M | 4.08M | 4.39M |
Selling and marketing | 100.74K | 0 | 0 | 0 | 7.43M | 0 | 0 | 0 |
Total operating expenses | 16.37M | 14.91M | 7.72M | 3.59M | 34.09M | 28.61M | 6.85M | 6.98M |
Operating income | -16.37M | -14.91M | -7.72M | -3.59M | -34.94M | -29.43M | -7.60M | -7.56M |
Other income (expenses), net | 955.00K | 588.10K | 17.72K | 15.11K | -12.01M | 559K | 423.39K | 1.87M |
Income before tax | -15.42M | -14.32M | -7.71M | -3.58M | -46.96M | -28.88M | -7.17M | -5.69M |
Income tax expense | 0 | -588.10K | -17.72K | -15.11K | 638K | 29K | -4 | 0 |
Net income | -15.42M | -13.73M | -7.69M | -3.56M | -47.59M | -28.90M | -7.17M | -5.69M |
Earnings per share | ||||||||
Basic EPS | -1.84 | -1.66 | -1.88 | -7.34 | -112.74 | -130.96 | -73.7 | -1.89 |
Diluted EPS | -1.84 | -1.66 | -1.88 | -7.34 | -112.74 | -130.96 | -73.7 | -1.89 |
| Data source | Data source | Data source |